Desjardins Global Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.24M | Buy |
14,469
+181
| +1% | +$28.1K | 0.24% | 91 |
|
|
2023
Q3 | $2.13M | Sell |
14,288
-4,318
| -23% | -$644K | 0.23% | 88 |
|
|
2023
Q2 | $2.51M | Buy |
18,606
+5,339
| +40% | +$719K | 0.29% | 73 |
|
|
2023
Q1 | $2.11M | Buy |
13,267
+7,755
| +141% | +$1.24M | 0.27% | 74 |
|
|
2022
Q4 | $890K | Buy |
5,512
+140
| +3% | +$22.6K | 0.14% | 149 |
|
|
2022
Q3 | $720K | Buy |
5,372
+174
| +3% | +$23.3K | 0.09% | 189 |
|
|
2022
Q2 | $796K | Sell |
5,198
-403
| -7% | -$61.7K | 0.1% | 176 |
|
|
2022
Q1 | $907K | Sell |
5,601
-211
| -4% | -$34.2K | 0.08% | 196 |
|
|
2021
Q4 | $786K | Buy |
+5,812
| New | +$786K | 0.07% | 225 |
|